🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Assisted reproduction treatment in patients with low ovarian reserve is a b...
Status
Unknown
Location
Multiple Locations
Start Date
2017-03
Trial ID
NCT03027843
Treatments Being Tested
To preliminary assess the efficacy and safety of recombinant human growth h...
Status
Completed
Location
Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology
Start Date
2009-12
Trial ID
NCT03221933
Treatments Being Tested
The purpose of this study is to determine whether treatment with Growth Hor...
Status
Recruiting
Location
Mayo Clinic
Start Date
2024-10-22
Trial ID
NCT06803589
Treatments Being Tested
This study aims to explore the optimal dose of pegylated recombinant human ...
Status
Unknown
Location
Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology
Start Date
2015-06
Trial ID
NCT03221088
Treatments Being Tested
This study aims to explore the optimal dose of pegylated recombinant human ...
Status
Unknown
Location
The First Affiliated Hospital with Nanjing Medical University
Start Date
2016-03
Trial ID
NCT03189160
Treatments Being Tested
Treatment for 3.5-8 weeks with GH (0.05 mg/kg/day) +GLN+Diet, followed by c...
Status
Terminated
Location
University of Nebraska Medical Center
Start Date
2003-09-01
Trial ID
NCT00742157
Treatments Being Tested
After the first stage (52 weeks) of Phase II clinical trial, Pegylated reco...
Status
Active Not Recruiting
Location
Beijing Children's Hospital, Capital Medical University, National Center for Children's Health
Start Date
2017-05-12
Trial ID
NCT03255694
Treatments Being Tested
To explore the dose-response relationship between pharmacokinetics and phar...
Status
Completed
Location
The Fourth Affiliated Hospital of Anhui Medical University
Start Date
2022-02-15
Trial ID
NCT05838885
This is a multiple-dose, dose-escalation, randomized, double-blind, placebo...
Status
Recruiting
Location
Peking University First Hospital
Start Date
2026-06-10
Trial ID
NCT07551804